Bio Path Holdings Inc

General ticker "BPTH" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $2.3M

Bio Path Holdings Inc does not follow the US Stock Market performance with the rate: -43.5%.

Estimated limits based on current volatility of 30.3%: low 0.97$, high 1.81$

Factors to consider:

  • Current price 78.1% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [5.06$, 16.37$]
  • 2024-12-30 to 2025-12-30 estimated range: [3.37$, 9.91$]

Financial Metrics affecting the BPTH estimates:

  • Negative: Non-GAAP EPS, $ of -40.80 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -70.65 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
  • Negative: negative Net income

Similar symbols

Short-term BPTH quotes

Long-term BPTH plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $10.44MM $13.90MM $15.84MM
Operating Income $-10.44MM $-13.90MM $-15.84MM
Non-Operating Income $0.00MM $0.03MM $-0.23MM
R&D Expense $5.91MM $9.16MM $11.61MM
Income(Loss) $-10.44MM $-13.87MM $-16.08MM
Profit(Loss) $-10.44MM $-13.87MM $-16.08MM
Stockholders Equity $25.46MM $14.17MM $0.44MM
Inventory $0.00MM $0.00MM $0.00MM
Assets $26.57MM $15.97MM $3.22MM
Operating Cash Flow $-9.92MM $-15.10MM $-11.54MM
Capital expenditure $0.07MM $0.02MM $0.00MM
Investing Cash Flow $-0.07MM $-0.02MM $0.00MM
Financing Cash Flow $20.01MM $1.73MM $2.20MM
Earnings Per Share* $-31.04 $-38.03 $-33.64

* EPS are Split Adjusted, recent splits may be reflected with a delay.